Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Government Contract opportunity was posted on September 30, 2019. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

National Cord Blood Inventory

Awarded
19-250-SOL-00062Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 621991
Federal
Human Cadaver - Based Medical Training and Program Support Services for the 44th Medical Brigade stationed at Fort Bragg Army Base, North Carolina.
Solicitation # 0012468284
The Medical Acquisition Support Office – Alpha is seeking capable vendors to provide human cadaver-based medical training and program support for the 44th Medical Brigade. The scope of work includes the procurement and delivery of up to 20 ethically sourced, non-dissected perfused whole-body cadaver specimens annually, which must be serologically negative for HIV, Hepatitis B/C, and Syphilis. The contractor is responsible for providing refrigerated transportation to primary performance sites at Fort Bragg, NC; Fort Campbell, KY; Fort Stewart-Hunter Army Airfield, GA; and Fort Polk, LA. Additionally, the contractor must provide rental medical equipment and consumable Class VIII supplies, such as surgical packs, tourniquets, and simulated blood. The requirement includes providing highly qualified Subject Matter Experts (SMEs) to support up to 10 training events per fiscal year. These SMEs must be board-certified general surgeons with specific competencies in various trauma procedures, such as cricothyroidotomy and exploratory laparotomy, to serve as instructors and mentors. The anticipated contract structure consists of a base period followed by four one-year option periods. All personnel must comply with strict Installation Access Control System requirements, including Anti-Terrorism Level I and iWatch training, to gain access to military installations.
W40M MRC0 West

POSTED

10 days ago

DEADLINE

in 1 day
NAICS: 621991
Federal
6505--Human Blood and Blood Products
Solicitation # 36C25727Q0049
The Department of Veterans Affairs, Network Contracting Office 17, intends to award a single-award, firm-fixed-price Indefinite Delivery/Indefinite Quantity (IDIQ) contract to the South Texas Blood and Tissue Center. This procurement is for the supply and delivery of human blood and blood products, as well as guidance in clinical pathology procedures, to support the Audie L. Murphy Veterans Health Care Center within the South Texas Veterans Health Care System in San Antonio, Texas. The government is pursuing this as a sole source procurement under the authority of 41 U.S.C. 3304(a)(1) and FAR 6.103-1, asserting that only one responsible source can satisfy the agency's requirements. The contractor must maintain AABB and College of American Pathologists (CAP) accreditation and hold an unrevoked U.S. license from the FDA Bureau of Biologics. Key operational requirements include 24/7/365 availability and a tiered delivery system: STAT orders must be delivered within 60 minutes, ASAP orders within 2 hours, and routine orders within 24 hours. All products must be collected via closed systems under aseptic conditions, labeled according to the ABO Blood Group System and Rh type, and transported in compliance with FDA, AABB, and DOT regulations to ensure proper temperature maintenance. Acceptance of deliveries is based on STVHCS Blood Bank criteria, including physical appearance, contamination checks, and specific shelf-life minimums for red blood cells, plasma, and cryoprecipitate.
257-NETWORK Contract Office 17 (36C257)

POSTED

14 days ago

DEADLINE

in 7 days
NAICS: 621991
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute (NCI) has issued a Limited Competition Notice of Funding Opportunity (RFA-CA-28-004) to support the continuation of two critical biospecimen banking resources: the National Clinical Trials Network (NCTN) Biobanks and the Early-Phase and Experimental Clinical Trials (EET) Biobank. The primary objective is to maintain these national resources for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens. These resources facilitate translational cancer research, biomarker development, and validation by providing essential specimens from NCI-funded clinical trials. The NCI intends to fund approximately six awards for fiscal year 2027, with a total estimated funding of 19 million dollars and a maximum budget of 3 million dollars in direct costs per year for a requested project period of six years. Applications will be evaluated through the NIH peer-review system based on scientific and technical merit, significance, and the adequacy of the institutional environment. Key requirements for applicants include maintaining active registrations in SAM, eRA Commons, and Grants.gov, as well as providing specific documentation regarding the current scale of operations, accomplishments, and standard operating procedures. Awardees must adhere to NCI Best Practices for Biospecimen Resources, federal human subjects regulations under 45 CFR 46, and strict cybersecurity incident reporting protocols, including notification of incidents within 48 hours of discovery. The scope of work includes managing secure informatics systems, providing specimen collection kits, and ensuring the availability of annotated biospecimens for authorized investigators.
National Institutes Of Health

POSTED

14 days ago

DEADLINE

in 3 months
NAICS: 621991
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute is issuing a limited competition Notice of Funding Opportunity, solicitation RFA-CA-28-004, to support the continuation of two critical biospecimen banking resources. These resources include the National Clinical Trials Network Biobanks, which support the NCTN and the Community Oncology Research Program, and the Early-Phase and Experimental Clinical Trials Biospecimen Bank, which supports the ETCTN and other early-phase experimental trials. The primary objective is to maintain national infrastructure for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the study of drug response and resistance. Eligible organizations must submit applications by February 12, 2027, to be considered for funding. All submissions will undergo a standard NIH peer-review process, and only meritorious applications will be selected. These banks are essential for linking biospecimens to clinical outcome data from large multi-site trials and supporting the development of novel cancer therapies through pharmacokinetic and pharmacodynamic analyses.
National Cancer Institute

POSTED

14 days ago

DEADLINE

in 4 months
NAICS: 621991
SLED
Mobile Health Unit OperationsThe contract titled Mobile Health Unit Operations seeks a subcontractor to manage the operation and maintenance of mobile units tasked with delivering vision, dental, and hearing services to underserved communities across the region. These mobile units will serve as critical access points for essential health care, ensuring that populations with limited transportation or geographic barriers receive timely and consistent medical attention. The work involves the full lifecycle management of the units, including routine maintenance, repairs, staffing coordination, logistics, and compliance with health and safety standards to guarantee reliable service delivery. The contract is categorized as a subcontract under NAICS code 621991 and is solicited by the Houston-Galveston Area Council through the Texas SmartBuy platform. The solicitation was posted on July 22, 2026, with a response deadline of July 29, 2027, providing over a year for prospective vendors to prepare proposals. The place of performance spans the region served by the council, though exact locations are not specified, indicating flexibility in service deployment based on community need. While details on set-aside status and point of contact are unavailable, the focus remains on operational excellence and equitable access to preventive and diagnostic health services in areas lacking permanent clinical infrastructure.
HOUSTON-GALVESTON AREA COUNCIL

POSTED

3 months ago

DEADLINE

in 9 months

AI Contract Overview

Show more

The Health Resources and Services Administration is seeking one or more qualified cord blood banks with approved U.S. Food and Drug Biologics License Applications to support the National Cord Blood Inventory. The primary objective is to collect and maintain at least 150,000 new, high-quality, and genetically diverse cord blood units for hematopoietic stem cell transplantation and peer-reviewed research. These units will be made available through the C.W. Bill Young Cell Transplantation Program. Selected contractors must operate their facilities according to FDA standards, implement rigorous donor screening and collection practices, and maintain a plan for financial and operational self-sufficiency. The contract is intended to be issued on a full and open basis with an initial five-year period of performance and a potential statutory extension of up to ten additional years. Performance will take place at the contractor's own facilities under the guidelines of FAR Part 15.

General Info

Agency

N/A

Contract Value

$5,560,934

NAICS

621991 - Blood and Organ Banks

Place of Performance

MD, USA

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

1 update
PhaseAwarded
Posted

Presolicitation

Notice updated

Response deadline added: Aug 21, 2019. The notice description changed. The point of contact changed.

Type Changed

Presolicitation → Solicitation

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Curtis LamContract Specialist

Full Description

Show more
This notice is provided pursuant to FAR 5.204 Action Code: Pre-solicitation Classification Code: The North American Industrial Classification System (NAICS) code for this acquisition is 621991 Blood and Organ Banks. Contracting Office Address: Health Resources and Services Administration Office of Acquisition Management and Policy 5600 Fishers Lane Room 14W31 Rockville, Maryland 20857 Subject: The Health Resources and Services Administration (HRSA), Healthcare Systems Bureau, Division of Transplantation to issue a solicitation for National Cord Blood Inventory (NCBI) Proposed Solicitation Number: 19-250-SOL-00062 Point of Contact: Curtis Lam, Contract Specialist; contact@example.gov; +1 (555) 000-0000 Place of Contract Performance: Contractor's facilities Description: THIS IS A PRESOLICATION NOTICE ONLY - The Health Resources and Services Administration (HRSA), Healthcare Systems Bureau, Division of Transplantation is planning to issue a solicitation to contract in accordance with the Stem Cell Therapeutic and Research Acts of 2005, 2010 and 2015 with one (1) or more qualified cord blood banks (CBBs), that have an approved U.S. Food and Drug Biologics License Application, to collect and maintain cord blood products for hematopoietic stem cell transplantation in order to meet the statutory goal of building a National Cord Blood Inventory (NCBI) of at least 150,000 new, high-quality, genetically diverse cord blood units (CBUs). The cord blood units (CBUs) shall be made available through the C.W. Bill Young Cell Transplantation Program (CWBYCTP) on the donor registry. Some donated cord blood units shall be made available for peer-reviewed research. In performing the activities of the NCBI, the Contractor shall: 1. Operate its established CBB with implemented donor screening, cord blood collection practices and processing methods intended to protect the health and safety of donors and transplant recipients to improve transplant outcomes; 2. Comply with its approved Biologics License Application as specified by the U.S. Food and Drug Administration for manufacturing and distributing cord blood products intended for unrelated donor transplantation; 3. Add licensed cord blood units to its public inventory from a genetically diverse group of donors; 4. Make CBUs available through the CWBYCTP; 5. Make CBUs available for peer-reviewed research; 6. Maintain a plan for self-sufficiency that demonstrating financial and operational sustainability through the contract period of performance, and recognizing Government funds for sustainability shall not be added to your contract each year; and 7. Comply with the requirements for the CWBYCTP, NCBI Program, and Cord Blood Bank accreditation standards from an NCBI accrediting organization recognized by HRSA. The solicitation will be issued as a full and open basis with a proposed initial period of performance of five (5) years and as required by statute with the option to extend the period of performance for 10- additional years from the last date that funds are obligated to the contract. The Government intends to issue a solicitation on or about beginning of July, 2019. The required services will be procured in accordance with FAR Part 15 - Contracting by Negotiation. All future information regarding this acquisition, including the solicitation and any amendments, will be distributed solely through the FedBizOpps website (www.fbo.gov). Copies of the solicitation document and its related documents, as appropriate, will be posted at this website. Interested parties are responsible for monitoring the FedBizOpps website to assure that they have the most up-to-date information regarding this acquisition. The Government will not reimburse interested parties for any costs associated with responding to this notice. For further information, please contact Curtis Lam, Contract Specialist, 5600 Fishers Lane, Rockville, MD 20857, +1 (555) 000-0000 and contact@example.gov.

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS